With the analysis among 235 patents, we discovered top 46 key players by total patent application. Regeneron Pharmaceuticals, Inc., Therapeutic Human Polyclonals, Inc., Amgen Fremont, Inc. are dominant in this area. They take 40.00% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 41
Therapeutic Human Polyclonals, Inc.
California, United States
Patent: 30
California, United States
Patent: 23
Virginia, United States
Patent: 17
GenPharm International LLC
California, United States
Patent: 10
California, United States
Patent: 9
Pennsylvania, United States
Patent: 8
Adaptive Biotechnologies Corp.
Washington, United States
Patent: 7
New Jersey, United States
Patent: 6
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 12 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Chongqing Jinmaibo Biotechnology Co., Ltd., Duke University take 83.33% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Chongqing Jinmaibo Biotechnology Co., Ltd.
Chongqing Shi, China
Patent: 2
North Carolina, United States
Patent: 2
Open Monoclonal Technology, Inc.
California, United States
Patent: 1
Therapeutic Human Polyclonals, Inc.
California, United States
Patent: 1
University Health Network
With the analysis among related 12 patents in last 5 years, we discover 1 new entrants.
With the analysis among 38 patents, we discovered top 7 universities and scientific research institutions by total patent application. Duke University, Swiss Federal Institute of Technology Zurich, Fudan University are dominant in this area. They take 76.32% of the total patent filing.
North Carolina, United States
Patent: 12
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 3
Shanghai Shi, China
Patent: 3
Korea Institute of Science & Technology
Aichi-ken, Japan
Patent: 1
Huazhong Agricultural University
Hubei Sheng, China
Patent: 1